ALKS vs CLOV
Alkermes Plc (ALKS) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ALKS and CLOV stock pages for the full models.
Not investment advice.